Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that eight abstracts have been accepted for presentation at the 2026 ASCO ...
Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...
Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback